Skip to Content

MYLAN 2046 MYLAN 2046 (Tacrolimus 1 mg)

Pill with imprint MYLAN 2046 MYLAN 2046 is Blue & Gray, Capsule-shape and has been identified as Tacrolimus 1 mg. It is supplied by Mylan Pharmaceuticals Inc..

Tacrolimus is used in the treatment of organ transplant, rejection prophylaxis; organ transplant, rejection reversal and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN 2046 MYLAN 2046

Tacrolimus 1 mg MYLAN 2046 MYLAN 2046
Tacrolimus 1 mg MYLAN 2046 MYLAN 2046
Tacrolimus 1 mg MYLAN 2046 MYLAN 2046
Tacrolimus 1 mg MYLAN 2046 MYLAN 2046

Tacrolimus

Imprint:
MYLAN 2046 MYLAN 2046
Strength:
1 mg
Color:
Blue & Gray
Size:
14.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Calcineurin inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mylan Pharmaceuticals Inc.
Inactive Ingredients:

Note: Inactive ingredients may vary.

Labelers / Repackagers:

NDC CodeLabeler / Repackager
00378-2046 Mylan Pharmaceuticals Inc.
51079-0818 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide